TSUMOYLE
LIVE

Serial Number

79246187

Owner

Clinuvel (UK) Ltd

Attorney

Michelle P. Ciotola

Filing Date

Sep 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TSUMOYLE Trademark

Serial Number: 79246187 • Registration: 5911072

TSUMOYLE is a trademark filed by Clinuvel (UK) Ltd on September 18, 2018. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Clinuvel (UK) Ltd (7 trademarks)

Devonshire House
London EC1M 7AD , GB

Entity Type: 99

Trademark Details

Filing Date

September 18, 2018

Registration Date

November 19, 2019

Published for Opposition

September 3, 2019

Cancellation Date

June 5, 2026

Goods & Services

Pharmaceuticals for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceuticals for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical drugs for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical drugs for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical preparations for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds, all used for the delivery and storage of pharmaceuticals containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide

Non-medicated skin care preparations; cosmetic preparations for skin care; cosmetic preparations for skin care, based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic oils; cosmetic skin creams; skin care creams, lotions and oils for cosmetic purposes; wrinkle removing skin care preparations; cosmetic sunscreen preparations; waterproof sunscreen; sunscreen preparations; sunscreen creams and lotions; cosmetics for protecting the skin from sunburn; sunblock lotions; cosmetic sun barriers; sun creams; cosmetic preparations for protecting the skin from the sun's rays; sun care lotions; cosmetic compounds for skin care after exposure to the sun's rays; after-sun milks, creams, lotions and moisturizers; sun skin bronzers; sun-tanning preparations; cosmetics for tanning the skin including preparations for tanning without sunlight, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin including preparations for tanning without sunlight, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic self-tanning preparations; self -tanning creams and lotions for cosmetic purposes; suntan creams, lotions, oils and gels; non-medicated skin rejuvenation preparations, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels; non-medicated skin rejuvenation products, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels with and without analogues of alpha-melanocyte stimulating hormone (alpha-MSH); non-medicated antiaging skincare preparations; antiaging creams, lotions, moisturizers, gels, balms and serums; skin cleansing creams, lotions, milks, foams, gels and masks for cosmetic purposes

Filing History

CANCELLED SECTION 71
Jun 5, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 19, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 27, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 11, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 11, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 19, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2019 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Oct 9, 2019 CHPB
ASSIGNED TO PETITION STAFF
Oct 9, 2019 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 10, 2019 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 30, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 14, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 14, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2019 CRFA
ASSIGNED TO LIE
Jul 16, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 11, 2019 TROA
REFUSAL PROCESSED BY IB
Feb 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 16, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 16, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 5, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 4, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 30, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 22, 2018 REPR